Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

被引：124

作者：

Pinheiro, Ruben G. R. ^{[1
]}

Coutinho, Ana Joyce ^{[1
]}

Pinheiro, Marina ^{[1
]}

Neves, Ana Rute ^{[1
,2
]}

机构：

[1] Univ Porto, LAQV, REQUIMTE, Dept Ciencias Quim,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal

[2] Univ Madeira, CQM Ctr Quim Madeira, Campus Penteada, P-9020105 Funchal, Portugal

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 21期

关键词：

Alzheimer's disease; drug delivery; drug targeting; neurodegenerative diseases; Parkinson's disease; SOLID LIPID NANOPARTICLES; PEG-PLA NANOPARTICLES; NICOTINIC ACETYLCHOLINE-RECEPTORS; IIB-IIIA COMPLEX; PLGA NANOPARTICLES; IN-VITRO; LOADED NANOPARTICLES; GLUCOSE TRANSPORTERS; TRANSFERRIN-RECEPTOR; TUMOR VASCULATURE;

D O I：

10.3390/ijms222111654

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The blood-brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the brain and target the desired anatomic region. The use of nanomedicine has great potential to overcome this problem, since one can modify nanoparticles with strategic molecules that can interact with the BBB and induce uptake through the brain endothelial cells and consequently reach the brain tissue. This review addresses the potential of nanomedicines to treat neurological diseases by using nanoparticles specially developed to cross the BBB.

引用

页数：22

共 50 条

[1] Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, Joerg
ADVANCED DRUG DELIVERY REVIEWS, 2014, 71 : 2 - 14
[2] Brain temperature: What do we know?
Rango, Mario
Arighi, Andrea
Bresolin, Nereo
NEUROREPORT, 2012, 23 (08) : 483 - 487
[3] Vesicular Transport Machinery in Brain Endothelial Cells: What We Know and What We Do not
Toth, Andrea E.
Holst, Mikkel R.
Nielsen, Morten S.
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (13) : 1405 - 1416
[4] Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform
Pinto, Miguel
Silva, Vera
Barreiro, Sandra
Silva, Renata
Remiao, Fernando
Borges, Fernanda
Fernandes, Carlos
AGEING RESEARCH REVIEWS, 2022, 79
[5] Voice tremor: what we know and what we do not know
Gillivan-Murphy, Patricia
Miller, Nick
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2011, 19 (03) : 155 - 159
[6] Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
Puris, Elena
Fricker, Gert
Gynther, Mikko
PHARMACEUTICAL RESEARCH, 2022, 39 (07) : 1415 - 1455
[7] Magnetic iron oxide nanoparticles for brain imaging and drug delivery
Qiao, Ruirui
Fu, Changkui
Forgham, Helen
Javed, Ibrahim
Huang, Xumin
Zhu, Jiayuan
Whittaker, Andrew K.
Davis, Thomas P.
ADVANCED DRUG DELIVERY REVIEWS, 2023, 197
[8] Intranasal Delivery of Paclitaxel-Loaded Ligand Conjugated Polymeric Nanoparticles for Targeted Brain Delivery
Deshmukh, Vishawambhar
Narwade, Mahaveer
Gajbhiye, Kavita Rai
AAPS PHARMSCITECH, 2025, 26 (02):
[9] PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
Cunha, Anthony
Gaubert, Alexandra
Latxague, Laurent
Dehay, Benjamin
PHARMACEUTICS, 2021, 13 (07)
[10] Amyloidogenesis: What Do We Know So Far?
Alraawi, Zeina
Banerjee, Nayan
Mohanty, Srujana
Kumar, Thallapuranam Krishnaswamy Suresh
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)

← 1 2 3 4 5 →